These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 24216479)
1. Isoprenylcysteine carboxylmethyltransferase deficiency exacerbates KRAS-driven pancreatic neoplasia via Notch suppression. Court H; Amoyel M; Hackman M; Lee KE; Xu R; Miller G; Bar-Sagi D; Bach EA; Bergö MO; Philips MR J Clin Invest; 2013 Nov; 123(11):4681-94. PubMed ID: 24216479 [TBL] [Abstract][Full Text] [Related]
2. Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice. He P; Yang JW; Yang VW; Bialkowska AB Gastroenterology; 2018 Apr; 154(5):1494-1508.e13. PubMed ID: 29248441 [TBL] [Abstract][Full Text] [Related]
3. Regulation of NOTCH signaling by RAB7 and RAB8 requires carboxyl methylation by ICMT. Court H; Ahearn IM; Amoyel M; Bach EA; Philips MR J Cell Biol; 2017 Dec; 216(12):4165-4182. PubMed ID: 29051265 [TBL] [Abstract][Full Text] [Related]
4. Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma. Mazur PK; Einwächter H; Lee M; Sipos B; Nakhai H; Rad R; Zimber-Strobl U; Strobl LJ; Radtke F; Klöppel G; Schmid RM; Siveke JT Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13438-43. PubMed ID: 20624967 [TBL] [Abstract][Full Text] [Related]
5. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS. Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346 [TBL] [Abstract][Full Text] [Related]
6. Isoprenylcysteine carboxylmethyltransferase is required for the impact of mutant KRAS on TAZ protein level and cancer cell self-renewal. Chai TF; Manu KA; Casey PJ; Wang M Oncogene; 2020 Jul; 39(31):5373-5389. PubMed ID: 32561852 [TBL] [Abstract][Full Text] [Related]
7. Notch1 is not required for acinar-to-ductal metaplasia in a model of Kras-induced pancreatic ductal adenocarcinoma. Avila JL; Troutman S; Durham A; Kissil JL PLoS One; 2012; 7(12):e52133. PubMed ID: 23284900 [TBL] [Abstract][Full Text] [Related]
8. Notch1 functions as a tumor suppressor in a model of K-ras-induced pancreatic ductal adenocarcinoma. Hanlon L; Avila JL; Demarest RM; Troutman S; Allen M; Ratti F; Rustgi AK; Stanger BZ; Radtke F; Adsay V; Long F; Capobianco AJ; Kissil JL Cancer Res; 2010 Jun; 70(11):4280-6. PubMed ID: 20484026 [TBL] [Abstract][Full Text] [Related]
9. The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models. Shen R; Wang Q; Cheng S; Liu T; Jiang H; Zhu J; Wu Y; Wang L Cancer Lett; 2013 Oct; 339(1):135-43. PubMed ID: 23887057 [TBL] [Abstract][Full Text] [Related]
10. Disruption of p16 and activation of Kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo. Qiu W; Sahin F; Iacobuzio-Donahue CA; Garcia-Carracedo D; Wang WM; Kuo CY; Chen D; Arking DE; Lowy AM; Hruban RH; Remotti HE; Su GH Oncotarget; 2011 Nov; 2(11):862-73. PubMed ID: 22113502 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of Isoprenylcysteine Carboxylmethyltransferase Induces Cell-Cycle Arrest and Apoptosis through p21 and p21-Regulated BNIP3 Induction in Pancreatic Cancer. Manu KA; Chai TF; Teh JT; Zhu WL; Casey PJ; Wang M Mol Cancer Ther; 2017 May; 16(5):914-923. PubMed ID: 28167504 [TBL] [Abstract][Full Text] [Related]
12. Early requirement of Rac1 in a mouse model of pancreatic cancer. Heid I; Lubeseder-Martellato C; Sipos B; Mazur PK; Lesina M; Schmid RM; Siveke JT Gastroenterology; 2011 Aug; 141(2):719-30, 730.e1-7. PubMed ID: 21684285 [TBL] [Abstract][Full Text] [Related]
13. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia. Kojima K; Vickers SM; Adsay NV; Jhala NC; Kim HG; Schoeb TR; Grizzle WE; Klug CA Cancer Res; 2007 Sep; 67(17):8121-30. PubMed ID: 17804724 [TBL] [Abstract][Full Text] [Related]
14. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues. Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419 [TBL] [Abstract][Full Text] [Related]
18. Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer. Zhang S; Chung WC; Xu K Oncogene; 2016 May; 35(19):2485-95. PubMed ID: 26279302 [TBL] [Abstract][Full Text] [Related]
19. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice. Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677 [TBL] [Abstract][Full Text] [Related]
20. Significance of Notch1-signaling pathway in human pancreatic development and carcinogenesis. Hu H; Zhou L; Awadallah A; Xin W Appl Immunohistochem Mol Morphol; 2013 May; 21(3):242-7. PubMed ID: 23235341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]